Harlan Labs Adds Industry Veteran

Philip Damiani, Ph.D. has been appointed head of Global Embryological Sciences and Transgenic Support at Harlan Laboratories. Dr. Damiani brings both scientific expertise and hands-on client experience. Dr. Damiani will oversee the company’s global contract breeding services, which include rederivation, cryopreservation, revitalization, colony management, contract breeding and quarantine services.   
 
Dr. Damiani has worked extensively in the field of assisted reproductive technology, including sperm and embryo cryopreservation, in vitro fertilization and nuclear transfer (cloning) for a wide variety of species. He is considered an expert in the areas of transgenic breeding, embryological cryopreservation and also owns several patents for cloning methods, including domestic and non-domestic species.  
 
Previously, Dr. Damiani served as head of Global Embryology for Taconic, where he was responsible for coordinating scientific R&D within the company’s embryology laboratories. Prior to that, he held progressive leadership roles at Genetic Savings and Clone, Inc., Advanced Cell Technology and Infigen, Inc.
 
“Philip is an ideal leader for our newly expanded contract breeding services given his extensive knowledge in assisted reproductive technology and experience managing a global team of research scientists,” said Doug Vaughan, president, Research Models and Services at Harlan Laboratories. “His leadership acumen and track record of success working with research scientists in leading pharmaceutical and academic centers aligns perfectly with our corporate commitment of being the most dependable supplier of contract breeding services in the industry.”